Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04561206 |
|---|---|
| Brief Title: | Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma |
| First Submitted : | September 10, 2020 |
| First Submitted that Met QC Criteria : | September 17, 2020 |
| First Posted : | September 23, 2020 |
| Last Update Submitted that Met QC Criteria : | September 14, 2023 |
| Last Update Posted : | September 15, 2023 |